Actively Recruiting
Evaluation of Safety and Performance of LuxBoost and LuxGood Intraocular Lenses in Adults with Cataracts
Led by Cutting Edge SAS · Updated on 2026-08-18
58
Participants Needed
2
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and performance of LuxBoost intraocular lenses IOLs implanted in both eyes, compared with the LuxGood Monofocal lens. This study focuses on adults aged 50 and over with bilateral cataracts, aiming to assess how well these lenses work when replacing the natural lens in cataract surgery. The trial is interventional and randomized, conducted by Cutting Edge SAS to compare these two devices. Participants will be randomly assigned to receive either the LuxBoost IOL or the LuxGood IOL, both implanted in the capsular bag to replace the cataractous human crystalline lens. The study measures vision quality outcomes at 4 and 6 months after surgery, including best corrected distance visual acuity CDVA and other vision tests like uncorrected distance, intermediate, and near visual acuity, as well as defocus curve assessments. During the study, participants will undergo regular follow-up visits to evaluate their vision and ensure the lenses are performing as expected. Researchers will monitor several vision measurements to compare the two lens types. Participants must be able to attend all follow-up visits and comply with examination procedures. The total study duration extends until mid-2028, with primary outcomes assessed around 4 to 6 months post-surgery.
CONDITIONS
Brief Title
Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL
Research Team
I
Ilham XHAARD
L
Line BETTINELLI
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here